Sarda Proteins Limited plans to raise up to Rs 10,000 crore through a rights issue of fully paid-up equity shares with a face value of Rs 10 each, as approved by the board on August 5, 2026; the rights issue will be offered to eligible shareholders as on a record date to be determined and notified later. The company has also approved a Draft Letter of Offer to be filed with SEBI and stock exchanges, and constituted a Rights Issue Committee to oversee the process, alongside appointing necessary intermediaries. Additionally, the board noted the resignation of non-executive director Gunvantray Jayantilal Zaladi, effective August 5, 2026, due to his inability to continue discharging his duties.
